Olena Bracho

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells”.

CUDC907, a dual phosphoinositide-3 kinase/histone deacetylase inhibitor, promotes apoptosis of NF2 Schwannoma cells

Oncotarget(2022)10.18632/oncotarget.28254

N/A

0DataRank · unranked

22 citations

Christine T. Dinh, Maria Martinelli, Olena Bracho, Rosa Rosario, Haley M. Hardin +6 more

RAD51 Inhibitor and Radiation Toxicity in Vestibular Schwannoma

Otolaryngology(2022)10.1177/01945998221083506

N/A

0DataRank · unranked

4 citations

Aida Nourbakhsh, Scott M. Welford, Eric A. Mellon, Olena Bracho, Michael E. Ivan +4 more

Cotargeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0135

N/A

0DataRank · unranked

6 citations

Christine T. Dinh, Julianne Huegel, Alejandra M. Petrilli, Olena Bracho, Abdulrahman Allaf +9 more

Interactions among Merlin, Arkadia, and SKOR2 mediate NF2-associated Schwann cell proliferation in human

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.24.614711

N/A

0DataRank · unranked

0 citations

Seyoung Um, Anderson B. Mayfield, Olena Bracho, Christian Castillo, Christine T. Dinh +3 more

Interactions among Merlin, Arkadia, and SKOR2 mediate NF2-associated human Schwann cell proliferation

Stem Cell Research & Therapy(2025)10.1186/s13287-025-04281-x

N/A

0DataRank · unranked

0 citations

Seyoung Um, Anderson B. Mayfield, Olena Bracho, Christian Castillo, Christine T. Dinh +3 more